Artiva Biotherapeutics is a startup based in the United States, 2 tracked investors.
Based in the United States, Artiva Biotherapeutics is a startup founded in 2018. Brouky records 2 investors associated with the company.
Artiva Biotherapeutics develops off-the-shelf natural killer (NK) cell-based immunotherapies for cancer, including engineered and CAR-NK products intended to provide scalable allogeneic cell therapy options.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.